-
Introduction of primary antibody and secondary antibody type, specificity and selection method in experiment
Time of Update: 2022-08-30
Which class or subclass does the primary antibody belong to Fragment specificity: 3.
Which class or subclass does the primary antibody belong to Fragment specificity: 3.
Which class or subclass does the primary antibody belong to Fragment specificity: 3.
-
Priority introduction and price exposure, the new crown neutralizing antibody welcomes the highlight moment?
Time of Update: 2022-08-15
3 New crown neutralizing antibody research and development is hot More than 30 domestic enterprises are deployed According to incomplete statistics, there are 7 types of COVID-19 neutralizing antibody therapies on the market globally, namely Casirizumab + Idezumab from Roche and Regeneron, and Atelizumab + Banivirumab from Eli Lilly.
-
Introduction to antibody
Time of Update: 2020-11-03
an antigen that activates many different B cells, produces many different antibodies, and combines with the different locations of the target molecule.
3. Immunotoxin: This method uses antibodies to carry toxic molecules that target tumor cells.
-
Introduction to Antibodies - Enzyme-Linked Immunosorbent Assay (ELISA)
Time of Update: 2020-10-31
Enzyme-linked Immunosorbent Assays (ELISAs)combine the specificity of antibodies with the sensitivity of simple enzyme assays, by using antibodies or antigens coupled to an easily assayed enzyme that possesses a high turnover number.
The assay is then quantitated by measuring the amount of labeled second antibody bound to the matrix, through the use of a colorimetric substrate.
-
Introduction of DKK1 antibody to explore PD-1 combined therapy
Time of Update: 2020-01-05
On January 3, Baekje Shenzhou and leap therapeutics, a biotech company targeting immunotherapy, announced that they had reached an exclusive option and license agreement on the clinical development an
